vs
GoodRx Holdings, Inc.（GDRX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
GoodRx Holdings, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.7倍（$194.8M vs $117.7M），GoodRx Holdings, Inc.净利率更高（2.8% vs -10.8%，领先13.5%），GoodRx Holdings, Inc.同比增速更快（-1.9% vs -19.2%），GoodRx Holdings, Inc.自由现金流更多（$31.6M vs $15.6M），过去两年GoodRx Holdings, Inc.的营收复合增速更高（-0.8% vs -11.8%）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
GDRX vs RGP — 直观对比
营收规模更大
GDRX
是对方的1.7倍
$117.7M
营收增速更快
GDRX
高出17.2%
-19.2%
净利率更高
GDRX
高出13.5%
-10.8%
自由现金流更多
GDRX
多$16.1M
$15.6M
两年增速更快
GDRX
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $117.7M |
| 净利润 | $5.4M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 11.6% | -10.3% |
| 净利率 | 2.8% | -10.8% |
| 营收同比 | -1.9% | -19.2% |
| 净利润同比 | -19.5% | 81.6% |
| 每股收益（稀释后） | $0.02 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXRGP
| Q4 25 | $194.8M | $117.7M | ||
| Q3 25 | $196.0M | $120.2M | ||
| Q2 25 | $203.1M | $139.3M | ||
| Q1 25 | $203.0M | $129.4M | ||
| Q4 24 | $198.6M | $145.6M | ||
| Q3 24 | $195.3M | $136.9M | ||
| Q2 24 | $200.6M | $148.2M | ||
| Q1 24 | $197.9M | $151.3M |
净利润GDRXRGP
| Q4 25 | $5.4M | $-12.7M | ||
| Q3 25 | $1.1M | $-2.4M | ||
| Q2 25 | $12.8M | $-73.3M | ||
| Q1 25 | $11.1M | $-44.1M | ||
| Q4 24 | $6.7M | $-68.7M | ||
| Q3 24 | $4.0M | $-5.7M | ||
| Q2 24 | $6.7M | $10.5M | ||
| Q1 24 | $-1.0M | $2.5M |
毛利率GDRXRGP
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
营业利润率GDRXRGP
| Q4 25 | 11.6% | -10.3% | ||
| Q3 25 | 7.5% | -1.7% | ||
| Q2 25 | 13.2% | -47.0% | ||
| Q1 25 | 11.5% | -38.4% | ||
| Q4 24 | 9.2% | -52.7% | ||
| Q3 24 | 10.5% | -3.5% | ||
| Q2 24 | 9.9% | 7.6% | ||
| Q1 24 | 3.7% | 2.8% |
净利率GDRXRGP
| Q4 25 | 2.8% | -10.8% | ||
| Q3 25 | 0.6% | -2.0% | ||
| Q2 25 | 6.3% | -52.6% | ||
| Q1 25 | 5.4% | -34.0% | ||
| Q4 24 | 3.4% | -47.2% | ||
| Q3 24 | 2.0% | -4.2% | ||
| Q2 24 | 3.3% | 7.1% | ||
| Q1 24 | -0.5% | 1.7% |
每股收益（稀释后）GDRXRGP
| Q4 25 | $0.02 | $-0.38 | ||
| Q3 25 | $0.00 | $-0.07 | ||
| Q2 25 | $0.04 | $-2.21 | ||
| Q1 25 | $0.03 | $-1.34 | ||
| Q4 24 | $0.01 | $-2.08 | ||
| Q3 24 | $0.01 | $-0.17 | ||
| Q2 24 | $0.02 | $0.31 | ||
| Q1 24 | $0.00 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $89.8M |
| 总债务越低越好 | $495.0M | — |
| 股东权益账面价值 | $616.3M | $194.6M |
| 总资产 | $1.4B | $289.3M |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资GDRXRGP
| Q4 25 | $261.8M | $89.8M | ||
| Q3 25 | $273.5M | $77.5M | ||
| Q2 25 | $281.3M | $86.1M | ||
| Q1 25 | $301.0M | $72.5M | ||
| Q4 24 | $448.3M | $78.2M | ||
| Q3 24 | $423.8M | $89.6M | ||
| Q2 24 | $524.9M | $108.9M | ||
| Q1 24 | $533.3M | $113.8M |
总债务GDRXRGP
| Q4 25 | $495.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $500.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDRXRGP
| Q4 25 | $616.3M | $194.6M | ||
| Q3 25 | $600.7M | $206.4M | ||
| Q2 25 | $643.0M | $207.1M | ||
| Q1 25 | $654.3M | $277.8M | ||
| Q4 24 | $724.7M | $325.7M | ||
| Q3 24 | $696.4M | $407.2M | ||
| Q2 24 | $669.4M | $418.8M | ||
| Q1 24 | $631.1M | $414.9M |
总资产GDRXRGP
| Q4 25 | $1.4B | $289.3M | ||
| Q3 25 | $1.3B | $287.2M | ||
| Q2 25 | $1.3B | $304.7M | ||
| Q1 25 | $1.3B | $375.6M | ||
| Q4 24 | $1.4B | $424.9M | ||
| Q3 24 | $1.4B | $512.9M | ||
| Q2 24 | $1.5B | $510.9M | ||
| Q1 24 | $1.5B | $523.2M |
负债/权益比GDRXRGP
| Q4 25 | 0.80× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $31.6M | $15.6M |
| 自由现金流率自由现金流/营收 | 16.2% | 13.2% |
| 资本支出强度资本支出/营收 | 0.6% | 0.3% |
| 现金转化率经营现金流/净利润 | 6.06× | — |
| 过去12个月自由现金流最近4个季度 | $164.4M | $24.3M |
8季度趋势，按日历期对齐
经营现金流GDRXRGP
| Q4 25 | $32.9M | $15.9M | ||
| Q3 25 | $76.0M | $-7.8M | ||
| Q2 25 | $49.6M | $16.8M | ||
| Q1 25 | $9.4M | $659.0K | ||
| Q4 24 | $44.7M | $1.8M | ||
| Q3 24 | $86.9M | $-309.0K | ||
| Q2 24 | $9.7M | $3.2M | ||
| Q1 24 | $42.6M | $20.5M |
自由现金流GDRXRGP
| Q4 25 | $31.6M | $15.6M | ||
| Q3 25 | $74.3M | $-8.0M | ||
| Q2 25 | $49.2M | $16.5M | ||
| Q1 25 | $9.3M | $238.0K | ||
| Q4 24 | $44.6M | $61.0K | ||
| Q3 24 | $86.5M | $-575.0K | ||
| Q2 24 | $9.4M | $3.0M | ||
| Q1 24 | $42.2M | $20.4M |
自由现金流率GDRXRGP
| Q4 25 | 16.2% | 13.2% | ||
| Q3 25 | 37.9% | -6.6% | ||
| Q2 25 | 24.2% | 11.8% | ||
| Q1 25 | 4.6% | 0.2% | ||
| Q4 24 | 22.4% | 0.0% | ||
| Q3 24 | 44.3% | -0.4% | ||
| Q2 24 | 4.7% | 2.1% | ||
| Q1 24 | 21.3% | 13.5% |
资本支出强度GDRXRGP
| Q4 25 | 0.6% | 0.3% | ||
| Q3 25 | 0.9% | 0.1% | ||
| Q2 25 | 0.2% | 0.2% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.1% | 1.2% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率GDRXRGP
| Q4 25 | 6.06× | — | ||
| Q3 25 | 67.94× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 6.64× | — | ||
| Q3 24 | 21.91× | — | ||
| Q2 24 | 1.45× | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
